197 related articles for article (PubMed ID: 25014541)
1. Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma.
Park YA; Choi CH; Do IG; Song SY; Lee JK; Cho YJ; Choi JJ; Jeon HK; Ryu JY; Lee YY; Kim TJ; Bae DS; Lee JW; Kim BG
Gynecol Oncol; 2014 Oct; 135(1):108-17. PubMed ID: 25014541
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.
Choi CH; Park YA; Choi JJ; Song T; Song SY; Lee YY; Lee JW; Kim TJ; Kim BG; Bae DS
Gynecol Oncol; 2012 Jul; 126(1):124-31. PubMed ID: 22525818
[TBL] [Abstract][Full Text] [Related]
3. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis.
Königshoff M; Wilhelm A; Jahn A; Sedding D; Amarie OV; Eul B; Seeger W; Fink L; Günther A; Eickelberg O; Rose F
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):640-50. PubMed ID: 17630322
[TBL] [Abstract][Full Text] [Related]
4. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN.
Diniz CRAF; Casarotto PC; Fred SM; Biojone C; Castrén E; Joca SRL
Neuropharmacology; 2018 Jun; 135():163-171. PubMed ID: 29550391
[TBL] [Abstract][Full Text] [Related]
6. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
[TBL] [Abstract][Full Text] [Related]
7. AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist.
Rhodes DR; Ateeq B; Cao Q; Tomlins SA; Mehra R; Laxman B; Kalyana-Sundaram S; Lonigro RJ; Helgeson BE; Bhojani MS; Rehemtulla A; Kleer CG; Hayes DF; Lucas PC; Varambally S; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10284-9. PubMed ID: 19487683
[TBL] [Abstract][Full Text] [Related]
8. The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention.
Renziehausen A; Wang H; Rao B; Weir L; Nigro CL; Lattanzio L; Merlano M; Vega-Rioja A; Del Carmen Fernandez-Carranco M; Hajji N; Matin R; Harwood C; Li S; Sim VR; O'Neill K; Evans A; Thompson A; Szlosarek P; Fleming C; Stebbing J; Proby C; Tzakos AG; Syed N; Crook T
Oncogene; 2019 Mar; 38(13):2320-2336. PubMed ID: 30478450
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.
Oh E; Kim JY; Cho Y; An H; Lee N; Jo H; Ban C; Seo JH
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1071-81. PubMed ID: 26975580
[TBL] [Abstract][Full Text] [Related]
10. The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis?
Pringle KG; Tadros MA; Callister RJ; Lumbers ER
Placenta; 2011 Dec; 32(12):956-62. PubMed ID: 22018415
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of angiotensin II type 1 and type 2 receptors at the maternal-fetal interface: potential roles in early placental development.
Tower CL; Lui S; Charlesworth NR; Smith SD; Aplin JD; Jones RL
Reproduction; 2010 Dec; 140(6):931-42. PubMed ID: 20837730
[TBL] [Abstract][Full Text] [Related]
12. Significance of intranuclear angiotensin-II type 2 receptor in oral squamous cell carcinoma.
Matsushima-Otsuka S; Fujiwara-Tani R; Sasaki T; Ohmori H; Nakashima C; Kishi S; Nishiguchi Y; Fujii K; Luo Y; Kuniyasu H
Oncotarget; 2018 Nov; 9(93):36561-36574. PubMed ID: 30564297
[TBL] [Abstract][Full Text] [Related]
13. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
15. Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes.
Thimm C; Erichsen L; Wruck W; Adjaye J
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445727
[TBL] [Abstract][Full Text] [Related]
16. The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: an in vitro study.
Namazi S; Rostami-Yalmeh J; Sahebi E; Jaberipour M; Razmkhah M; Hosseini A
Biomed Pharmacother; 2014 Jun; 68(5):565-71. PubMed ID: 24975086
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
Zhang Q; Yu S; Lam MMT; Poon TCW; Sun L; Jiao Y; Wong AST; Lee LTO
J Exp Clin Cancer Res; 2019 Mar; 38(1):116. PubMed ID: 30845964
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells.
Namazi S; Sahebi E; Rostami-Yalmeh J; Jaberipour M; Razmkhah M; Hosseini A; Arabsolghar R
Tumour Biol; 2015 Feb; 36(2):893-900. PubMed ID: 25304158
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
